# FDA Inspection 1016494 - Biotest Pharmaceuticals Corporation - February 08, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals-corporation/7eae565c-00e9-4436-abe6-b57633ae14fc
Source feed: FDA_Inspections

> FDA Inspection 1016494 for Biotest Pharmaceuticals Corporation on February 08, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1016494
- Company Name: Biotest Pharmaceuticals Corporation
- Inspection Date: 2017-02-08
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1257057 - 2024-11-21](https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals-corporation/2cb0b39b-348d-42d1-9081-771ccfb1a121)
- [FDA Inspection 1257057 - 2024-11-21](https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals-corporation/7bafc8f7-6ca8-4522-9c80-c927eb532c97)
- [FDA Inspection 1088827 - 2019-04-17](https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals-corporation/facfc12d-2398-4166-bca9-77eae6d6a20a)

Company: https://www.globalkeysolutions.net/companies/biotest-pharmaceuticals-corporation/72f08a9c-cb76-4d48-93b5-515600473841

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d